Actavis Warning Letter Adds Fuel To Pliva Takeover Battle
Barr says FDA warning letter demonstrates Actavis’ inability to integrate acquisitions like Pliva.
Barr says FDA warning letter demonstrates Actavis’ inability to integrate acquisitions like Pliva.